Indrayani Biotech Ltd

Indrayani Biotec Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Indrayani Biotech Ltd

₹ 13.5 -0.81%
15 Dec - close price
indrayani.com BSE: 526445
About

Incorporated in 1992, Indrayani Biotech
Ltd is in the business of Foods & Hospitality, Engineering and Healthcare[1]

Key Points

Business Overview:[1]
IBL has multiple business units managed by an
independent team of field experts. It operates
in Food and Hospitality, Dairy, Healthcare & Pharma, Engineering, Biotech, Agriculture and Infrastructure

Website BSE
  • Market Cap ₹ 61.4 Cr.
  • Current Price ₹ 13.5
  • High / Low ₹ 37.9 / 10.2
  • Stock P/E
  • Book Value ₹ 16.6
  • Dividend Yield 0.00 %
  • ROCE -1.12 %
  • ROE -8.75 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Stock is trading at 0.81 times its book value

Cons

  • Company has low interest coverage ratio.
  • Promoter holding is low: 33.3%
  • Company has a low return on equity of 5.79% over last 3 years.
  • Company might be capitalizing the interest cost
  • Earnings include an other income of Rs.5.64 Cr.
  • Company has high debtors of 164 days.
  • Promoter holding has decreased over last 3 years: -11.6%
  • Working capital days have increased from 114 days to 211 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Fast Moving Consumer Goods Fast Moving Consumer Goods Agricultural Food & other Products Other Agricultural Products

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025
42.05 46.00 49.25 42.31 40.44 39.09 44.38 31.53 30.81 17.32 50.57 29.10 35.95
36.85 40.67 46.07 39.77 33.15 35.64 34.21 25.55 25.70 14.40 53.45 26.92 33.50
Operating Profit 5.20 5.33 3.18 2.54 7.29 3.45 10.17 5.98 5.11 2.92 -2.88 2.18 2.45
OPM % 12.37% 11.59% 6.46% 6.00% 18.03% 8.83% 22.92% 18.97% 16.59% 16.86% -5.70% 7.49% 6.82%
1.96 0.08 2.05 0.01 0.09 0.08 1.03 0.04 0.30 0.00 2.78 1.06 1.80
Interest 1.15 1.21 2.23 2.03 0.93 1.41 5.51 0.83 1.42 1.03 -1.72 2.17 1.89
Depreciation 0.75 0.78 1.15 0.90 0.91 1.03 0.96 4.25 2.79 1.46 9.93 0.86 1.30
Profit before tax 5.26 3.42 1.85 -0.38 5.54 1.09 4.73 0.94 1.20 0.43 -8.31 0.21 1.06
Tax % 0.00% -0.88% 21.62% 15.79% 0.00% 0.00% 0.00% 9.57% -1.67% 18.60% 2.53% 23.81% 14.15%
5.26 3.44 1.44 -0.45 5.54 1.08 4.73 0.85 1.22 0.35 -8.53 0.16 0.91
EPS in Rs 1.54 0.72 0.32 -0.13 1.62 0.22 0.85 0.19 0.27 0.05 -1.87 0.04 0.20
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2010 Mar 2011 Mar 2012 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
0 39 58 50 21 61 163 165 130 133
0 39 57 47 26 54 145 142 115 128
Operating Profit -0 1 1 3 -5 7 17 24 15 5
OPM % -105% 2% 1% 6% -24% 11% 11% 14% 12% 4%
0 0 0 0 -4 0 4 1 3 6
Interest 0 0 0 1 2 2 6 10 3 3
Depreciation 0 0 0 1 0 1 3 4 21 14
Profit before tax -0 0 0 1 -11 4 12 11 -6 -7
Tax % 0% 150% 300% 0% 0% 0% 3% 5% 6%
-0 -0 -0 1 -11 4 12 10 -6 -7
EPS in Rs -0.14 -0.16 2.22 -3.28 1.30 2.55 1.40 -1.34 -1.58
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 21%
3 Years: 29%
TTM: -9%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: -204%
Stock Price CAGR
10 Years: 1%
5 Years: 12%
3 Years: -47%
1 Year: -63%
Return on Equity
10 Years: %
5 Years: 3%
3 Years: 6%
Last Year: -9%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2010 Mar 2011 Mar 2012 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 6 4 4 4 34 34 34 46 46 46
Reserves -6 -0 -0 27 -15 -10 12 22 27 30
0 0 0 14 16 19 79 113 137 146
1 6 9 7 5 8 31 54 59 52
Total Liabilities 1 10 12 51 40 51 156 234 268 274
1 6 6 17 15 17 57 62 58 62
CWIP -0 0 0 14 14 13 14 20 26 23
Investments 0 0 0 0 0 0 0 0 0 0
0 4 7 21 11 22 85 151 185 189
Total Assets 1 10 12 51 40 51 156 234 268 274

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2010 Mar 2011 Mar 2012 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
1 2 6 0 4 16 -30 -7
-3 -0 -4 -1 -1 -47 -16 25
2 -1 -1 -0 -3 33 44 -18
Net Cash Flow 0 1 1 -1 1 2 -2 -0

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2010 Mar 2011 Mar 2012 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 0 26 26 52 84 84 67 87 164
Inventory Days 365 57 25 14 44 159 146
Days Payable 365 70 77 52 81 141 83
Cash Conversion Cycle 0 26 26 38 32 46 30 106 227
Working Capital Days -1,883 -22 -19 30 -59 -12 6 127 211
ROCE % 28% 12% -13% 16% 23% 14% -1%

Shareholding Pattern

Numbers in percentages

1 Recently
Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
44.89% 44.89% 44.89% 44.84% 33.63% 33.57% 33.48% 33.40% 33.28% 33.28% 33.28% 33.26%
17.16% 17.02% 15.27% 13.11% 7.58% 6.75% 4.07% 5.59% 5.25% 3.66% 3.11% 3.13%
37.96% 38.09% 39.84% 42.05% 58.78% 59.68% 62.46% 61.01% 61.49% 63.07% 63.62% 63.61%
No. of Shareholders 22,11221,91922,43522,59023,03423,95824,13224,41925,25425,12625,70425,686

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports